Jennifer Gass, PhD, FACMG, associate director, Genetics Laboratory, Florida Cancer Specialists & Research Institute, discusses the recent Genetics Laboratory, which focuses on next-generation sequencing (NGS) testing in oncology care.
The state-of-the-art Florida Cancer Specialists & Research Institute (FCS) laboratory provides next-generation sequencing (NGS) testing, which helps oncologists identify genetic mutations in hundreds of different genes, all at once.
Transcript
How are things going and who is the team at the team at the new NGS laboratory that opened about a year ago at FCS?
Our pathology lab is made up of 8 different pathologist, 2 laboratory geneticist, and multiple departments. My department is the molecular department, and we are the ones that run the next generation sequencing (NGS). And within that department, we have 10 technologists and 2 variants scientists, as well as a molecular manager to support our NGS testing.
Everything is going well! we launched our first NGS test in July of 2021 and now we have brought on another test, so we support both solid tumor and hematological malignancies. And we look forward to bringing on more technologies with NGS as well as more molecular technologies.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More